IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aprea Therapeutics Inc (APRE)

CUSIP: 03836J201 | NYSE | Healthcare · Biotechnology | Micro Cap | 59 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/ALytton Laurence W390,8073.2%Newly reportedJun 30, 2026No 13F filer matched
13G/ALytton Laurence W390,807
3.2% of class · Jun 30, 2026

Institutional Holders — Q3 2026

Aigh Capital Management LLC1,015,541
0.1% of portfolio›$761.7K
Geode Capital Management, LLC74,549
0.0% of portfolio›$55.9K
LPL Financial LLC19,052
0.0% of portfolio›$14.3K
TD Waterhouse Canada Inc.40
0.0% of portfolio›$29
SBI Securities Co., Ltd.16
0.0% of portfolio›$12
Barclays PLC2
0.0% of portfolio›$2
StyleTurnoverLocationFiled
Aigh Capital Management LLC
1,015,541$761.7K0.1%GARPVery HighBaltimore, MD2026-11-02
Geode Capital Management, LLC
74,549$55.9K0.0%IndexVery LowBoston, MA2026-11-06
LPL Financial LLC
19,052$14.3K0.0%IndexVery LowFort Mill, SC2026-11-06
TD Waterhouse Canada Inc.
40$290.0%CoreLowToronto, Australia2026-10-16
SBI Securities Co., Ltd.
16$120.0%GrowthLowTokyo, Mexico2026-10-22
Barclays PLC
2$20.0%GrowthMediumLondon, United Kingdom2026-11-06
Newly reported
No 13F filer matched